Revolutionizing the Supply Chain: Direct-to-Patient (DtP) Logistics in Decentralized Trials
The success of any pharmaceutical study relies on the flawless administration of the Investigational Medicinal Product (IMP). In a traditional setting, bulk shipments of the drug are delivered to a central hospital pharmacy, where they are stored and dispensed directly to the patient by a clinical pharmacist. Removing the hospital from this equation entirely disrupts the global clinical supply...
0 Kommentare 0 Geteilt 655 Ansichten 0 Bewertungen